drugset / Trial / NCT03063788
Imaging the HIV Reservoir
Phase 1
Completed
17 enrolled
Bayside Health
Austin Health · collabMonash Health · collabMonash University · collabRockefeller University · collabThe Peter Doherty Institute for Infection and Immunity · collab
Non-randomizedSequentialOpen-labelDiagnostic
Summary
Radiolabelling broadly neutralizing anti-HIV antibody 3BNC117 with a Copper-64 radio isotope for infusion into people with HIV followed by MRI/PET scanning to detect HIV in vivo.
Timeline
- Start
- 2018-09-18
- Primary completion
- 2020-02-01
- Completion
- 2020-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAFUVITUG | Monoclonal antibody | 3 mg/kg | Intravenous |